Matthew Pontzer
Psychiatry · Fort Carson, CONPI 1598736860
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 94 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,517 and has fallen 67.3% since, to $496 in 2024. Among psychiatry clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 94 payments — averaging $23.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$332
- Tris Pharma Inc$305
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$283
- Lundbeck LLC$175
- Alkermes, Inc.$170
- Takeda Pharmaceuticals U.S.A., Inc.$162
- plus $759 from 13 others
What the payments were for
- Food & beverage$2,15599%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 14 | $332 |
| Tris Pharma Inc | 6 | $305 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $283 |
| Lundbeck LLC | 7 | $175 |
| Alkermes, Inc. | 9 | $170 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $162 |
| Neurocrine Biosciences, Inc. | 6 | $118 |
| Otsuka America Pharmaceutical, Inc. | 5 | $113 |
| Teva Pharmaceuticals USA, Inc. | 4 | $107 |
| Ironshore Pharmaceuticals Inc. | 5 | $85 |
| Corium, LLC | 3 | $72 |
| Idorsia Pharmaceuticals US Inc | 3 | $56 |
| Avion Pharmaceuticals | 2 | $48 |
| Noven Therapeutics, LLC | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $34 |
| Indivior Inc. | 2 | $31 |
| Supernus Pharmaceuticals, Inc. | 2 | $29 |
| Sage Therapeutics, LLC | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
How this compares
$2,185 in reported general payments places this provider in the 90th percentile of 559 psychiatry providers in Colorado.
Other psychiatry in Fort Carson
- John HardyPueblo$828K
- Larry SandersLittleton$760K
- Jeffrey RichmondDenver$424K
- Jennifer FrenchGlendale$115K
- Charles ParkLone Tree$89K
- Cynthia EppersonAurora$64K
- Brian WiseCentennial$44K
- Robert CowanCentennial$29K
- Brenda CzabanDenver$25K
- John DequardoPueblo$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.